Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
10/2005
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581491A1 Indole derivatives as ppar modulators
10/05/2005EP1581472A2 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
10/05/2005CN1221548C Oxazolidinones having sulfoximine functional group
10/05/2005CN1221547C Linezolid-crystal form II
10/04/2005US6951945 Heteroaromatic glucokinase activators
10/04/2005US6951849 Psychological disorders; central nervous system disorders; schizophrenia
10/04/2005CA2243706C Azolyl piperazinyl phenyl oxazolidinone antimicrobials
09/2005
09/29/2005WO2005090339A1 New antibacterial agents
09/29/2005WO2005090302A2 Palladium catalyzed indolization of 2-bromo or chloroanilines
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005090292A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005012271A3 Process for the synthesis of biaryl oxazolidinones
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215596 Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals
09/29/2005US20050214828 Using ultrviolet laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics
09/29/2005CA2559919A1 Sulphonamide derivatives
09/29/2005CA2558051A1 Palladium catalyzed indolization of 2-bromo or chloroanilines
09/29/2005CA2554609A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1580187A1 Apoptogenic and antiproliferative analogs of ceramide
09/28/2005EP1578735A1 Cyclopentyl glutaramides and their use as neutral endopeptidase inhibitors
09/28/2005EP1578734A1 Novel antibacterial agents
09/28/2005EP1578723A2 Process for the preparation of oxazolidinones and method of use thereof
09/28/2005EP1578716A1 Dicarboxylic acid derivatives as ppar-agonists
09/28/2005EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/28/2005EP1373230B1 Enantioselective synthesis of azetidinone intermediate compounds
09/28/2005CN1675187A Co-surfactants based on aldehydes
09/28/2005CN1675185A Therapeutic molecules and methods-1
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1673224A N-[4(R)-(1, 3-dioxane)methyl] aniline and its prepn and use
09/28/2005CN1220685C Method for continuously preparing substituted oxazole
09/27/2005US6949654 Treating diseases arising from reactive oxygen species and/or excess Zn ions, in particular stroke, Parkinson's disease and Alzheimer's disease.
09/27/2005US6949566 For use as metalloproteinase inhibitors
09/27/2005US6949557 Hydroanthracene based compounds as anticancer agents
09/27/2005US6949551 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides
09/22/2005WO2005089025A1 Organic electroluminescent device
09/22/2005WO2005087752A2 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005WO2005087235A1 Pyrrolidine compounds
09/22/2005WO2005087232A1 Bicyclic modulators of androgen receptor function
09/22/2005US20050209465 By reacting with substituted acetylenes in the presence of a phosphine ligand and a base (K2CO3); used to make drugs
09/22/2005US20050209279 Process for production of piperidine derivatives
09/22/2005US20050209275 Beta 2-adrenergic receptor agonists
09/22/2005US20050209241 Benzoyl-piperazine derivatives
09/22/2005US20050208537 Very large scale immobilized polymer synthesis
09/22/2005DE102004010893A1 Neue ß-Ketoamid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New ß-keto amide compounds with MCH-antagonistic effect and pharmaceutical compositions containing them
09/22/2005DE10100772B4 Ether- und Amidverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Antidiabetika Ether and amide compounds, processes for their preparation and their use as antidiabetic agents
09/22/2005CA2558036A1 Substituted hydroxyethylamine aspartyl protease inhibitors
09/21/2005EP1575922A1 Biphenyl derivatives and their use as fungicides
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005EP1575900A1 N-methyl amino acids
09/21/2005EP1096934B1 Oxazolidinones to treat eye infections
09/21/2005CN1671384A Methods of treating microbial infections in humans and animals
09/21/2005CN1219759C Intermediate for preparing substitated biphenyl oxazoline compounds
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005WO2005085221A1 Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds
09/15/2005WO2005085218A1 A novel process for preparing valdecoxib
09/15/2005WO2005084349A2 Compounds useful for the synthesis of (+)-discodermolide and methods therefor
09/15/2005WO2005055940A3 Novel m3 muscarinic acetylcholine receptor antagonists
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005US20050203147 Biaryl heterocyclic compounds and methods of making and using the same
09/15/2005US20050203144 Use against multi-drug resistant staphylococci, streptococci, enterococci, Bacteroides, Clostridia, Mycobacterium tuberculosis; e.g. N-[5(S)-3-[3,5-Difluoro-4-[(1alpha,5alpha,6alpha )-6-[(2-(1,3-dihydroxy)propyloxy)iminomethyl]-3-azabicyclo[3.1.0]hexan-3-yl]phenyl]-2-oxooxazolidin-5-ylmethyl]acetamide
09/15/2005US20050203102 Oxazolidinone derivatives such as (S)-N-[3-[3-fluoro-4-[4-[4-[(3-carboxymethyl-5-oxo-2-thioxo-1,3-thiazolidin-3-yl)methine]phenyl]piperazin-1 -yl]phenyl]-2-oxooxazolidin-5-ylmethyl] acetamide; antibiotics; use against Vancomycin resistant organisms, methicillin resistant organisms
09/15/2005CA2552907A1 Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds
09/14/2005EP1572203A1 Substituted 4-alkoxyoxazol derivatives as ppar agonists
09/14/2005EP1572129A2 Amidine derivatives for treating amyloidosis
09/14/2005EP1499609A4 Pesticidal heterocycles
09/14/2005EP1385834B1 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005CN1668606A Oxazole derivatives and their use as insulin sensitizers
09/14/2005CN1668595A Method of forming a carbon-carbon or carbon-heteroatom linkage
09/14/2005CN1666984A Process for extracting epigoitrin from isatis root and use thereof
09/09/2005WO2005083771A1 Assembly of a semiconductor die attached to substrate with oxazoline derivative bearing an electron donor or acceptor functionality
09/09/2005WO2005082900A2 Oxazolidinone amidoximes as antibacterial agents
09/09/2005WO2005082871A2 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
09/09/2005WO2005082868A1 Compounds as inhibitors of cell proliferation and viral infections
09/09/2005WO2005061468A8 Halogenated biaryl heterocyclic compounds and methods of making and using the same
09/09/2005CA2556616A1 Compounds as inhibitors of cell proliferation and viral infections
09/08/2005US20050197369 Compounds useful for the synthesis of (+)-discodermolide and methods therefor
09/08/2005US20050197359 Bicyclic modulators of androgen receptor function
09/08/2005US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005CN1665802A Bisarylsulfonamide compounds and their use in cancer therapy
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665500A Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
09/07/2005CN1665475A Merocyanine derivatives for cosmetic use
09/07/2005CN1217940C Naphthol derivatives
09/07/2005CN1217933C Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
09/07/2005CN1217903C Substituted biphenyl oxazoline
09/06/2005US6939967 Non-proteinogenic L-amino acids
09/06/2005US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine,
09/06/2005CA2067690C Amino acid derivatives
09/01/2005WO2005080360A1 Compounds
09/01/2005WO2005080357A2 Oxazole derivatives, preparation and therapeutic use therof
09/01/2005WO2005080334A1 Novel heterocyclic compound
09/01/2005WO2005080322A1 Fluorene derivative
09/01/2005WO2005080317A2 Therapeutic amide derivatives
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 210